Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by episodic memory deficits, brain gray matter atrophy, and pathological features such as amyloid-β plaques, hyperphosphorylated tau, and neuronal dysfunction (Aisen et al., 2017; Jack et al., 2024). The gene discussed is MAPT; the disease is Alzheimer disease.